Long non-coding RNAs in vascular biology and disease.


Journal

Vascular pharmacology
ISSN: 1879-3649
Titre abrégé: Vascul Pharmacol
Pays: United States
ID NLM: 101130615

Informations de publication

Date de publication:
03 2019
Historique:
received: 24 12 2017
revised: 28 03 2018
accepted: 28 03 2018
entrez: 27 3 2019
pubmed: 27 3 2019
medline: 29 5 2019
Statut: ppublish

Résumé

The advent of deep sequencing technologies recently unraveled the complexity of the human genome: Although almost entirely transcribed, only a very minor part of our genome actually accounts for protein coding exons and most is considered non-coding. Among the non-coding transcripts, long non-coding RNAs (lncRNAs) constitute a rather heterogeneous group of linear as well as circular RNAs (circRNAs). LncRNAs act via multiple mechanisms and several lncRNAs were shown to be involved in vascular development, growth and remodeling. For example, the lncRNAs PUNISHER, MALAT1, MEG3, and GATA6-AS regulate vessel formation in vivo, whereas lincRNA-p21 controls smooth muscle cell function and neointima formation. For several other lncRNAs (e.g. SENCR, SMILR, and HypERlnc) functional roles in smooth muscle cells/pericytes have been described in vitro. Less information is available with respect to the function of circRNAs. Here most studies report on expression profiles but some circRNAs (e.g. cANRIL or cZNF292) may also play critical roles in smooth muscle or endothelial cells in vitro. This review summarizes the current knowledge of lncRNA and circRNA functions in vascular biology and disease and discusses their potential use as biomarkers.

Identifiants

pubmed: 30910127
pii: S1537-1891(17)30467-6
doi: 10.1016/j.vph.2018.03.003
pii:
doi:

Substances chimiques

Genetic Markers 0
RNA, Long Noncoding 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Nicolas Jaé (N)

Institute for Cardiovascular Regeneration, Goethe University, Frankfurt am Main 60590, Germany.

Andreas W Heumüller (AW)

Institute for Cardiovascular Regeneration, Goethe University, Frankfurt am Main 60590, Germany.

Youssef Fouani (Y)

Institute for Cardiovascular Regeneration, Goethe University, Frankfurt am Main 60590, Germany.

Stefanie Dimmeler (S)

Institute for Cardiovascular Regeneration, Goethe University, Frankfurt am Main 60590, Germany. Electronic address: Dimmeler@em.uni-frankfurt.de.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH